The role of stem cell transplantation in the treatment of follicular lymphoma

Seminars in Cancer Biology

Volumn 13, Issue 3, 2003, Pages 233-239

  Finke, Jürgen ^a  

^a UNIVERSITY OF FREIBURG   (Germany)

Author keywords

Follicular lymphoma; Stem cell transplantation; Treatment

Indexed keywords

CISPLATIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; DOXORUBICIN; ETOPOSIDE; MELPHALAN; MITOXANTRONE; MYELOABLATIVE AGENT; PREDNISONE; RITUXIMAB; VINCRISTINE; VINDESINE;

AUTOLOGOUS BONE MARROW TRANSPLANTATION; BLOOD; BONE MARROW; CANCER CHEMOTHERAPY; CHROMOSOME TRANSLOCATION; CLINICAL TRIAL; DRUG MEGADOSE; FOLLICULAR LYMPHOMA; GRAFT VERSUS HOST REACTION; HUMAN; MINIMAL RESIDUAL DISEASE; POLYMERASE CHAIN REACTION; RELAPSE; REMISSION; REVIEW; STEM CELL TRANSPLANTATION; SURVIVAL;

EID: 0038294703     PISSN: 1044579X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1044-579X(03)00019-1     Document Type: Review

References (49)

1. Horning S.J., Rosenberg S.A. The natural history of initially untreated low-grade non-Hodgkin's lymphomas. N. Engl. J. Med. 311:1984;1471-1475.
2. Johnson P.W., Rohatiner A.Z., Whelan J.S., Price C.G., Love S., Lim J.et al. Patterns of survival in patients with recurrent follicular lymphoma: a 20-year study from a single center. J. Clin. Oncol. 13:1995;140-147.
3. Lopez-Guillermo A., Montserrat E., Bosch F., Terol M.J., Campo E., Rozman C. Applicability of the international index for aggressive lymphomas to patients with low-grade lymphoma. J. Clin. Oncol. 12:1994;1343-1348.
4. Bastion Y., Coiffier B. Is the international prognostic index for aggressive lymphoma patients useful for follicular lymphoma patients? J. Clin. Oncol. 12:1994;1340-1342.
5. Federico M., Vitolo U., Zinzani P.L., Chisesi T., Clo V., Bellesi G.et al. Prognosis of follicular lymphoma: a predictive model based on a retrospective analysis of 987 cases. Intergruppo Italiano Linfomi. Blood. 95:2000;783-789.
6. Rodriguez J., McLaughlin P., Hagemeister F.B., Fayad L., Rodriguez M.A., Santiago M.et al. Follicular large cell lymphoma: an aggressive lymphoma that often presents with favorable prognostic features. Blood. 93:1999;2202-2207.
7. Gribben J.G., Goldstone A.H., Linch D.C., Taghipour G., McMillan A.K., Souhami R.L.et al. Effectiveness of high dose combination chemotherapy and autologous bone marrow transplantation for patients with non-Hodgkin's lymphomas who are still responsive to conventional-dose therapy. J. Clin. Oncol. 7:1989;1621-1629.
8. Gribben J.G., Freedman A.S., Neuberg D., Roy D.C., Blake K.W., Woo S.D.et al. Immunologic purging of marrow assessed by PCR before autologous bone marrow transplantation for B-cell lymphoma. N. Engl. J. Med. 325:1991;1525-1533.
9. Freedman A.S., Gribben J.G., Nadler L.M. High dose therapy and autologous stem cell transplantation in follicular non-Hodgkin's lymphoma. Leuk. Lymphoma. 28:1998;219-230.
10. Bastion Y., Brice P., Haioun C., Sonet A., Salles G., Marolleau J.P.et al. Intensive therapy with peripheral blood progenitor cell transplantation in 60 patients with poor-prognosis follicular lymphoma. Blood. 86:1995;3257-3262.
11. Haas R., Moos M., Karcher A., Mohle R., Witt B., Goldschmidt H.et al. Sequential high dose therapy with peripheral-blood progenitor-cell support in low-grade non-Hodgkin's lymphoma. J. Clin. Oncol. 12:1994;1685-1692.
12. Bierman P.J., Vose J.M., Anderson J.R., Bishop M.R., Kessinger A., Armitage J.O. High dose therapy with autologous hematopoietic rescue for follicular low-grade non-Hodgkin's lymphoma. J. Clin. Oncol. 15:1997;445-450.
13. Apostolidis J., Gupta R.K., Grenzelias D., Johnson P.W., Pappa V.I., Summers K.E.et al. High dose therapy with autologous bone marrow support as consolidation of remission in follicular lymphoma: long-term clinical and molecular follow-up. J. Clin. Oncol. 18:2000;527-536.
14. Cao T.M., Horning S., Negrin R.S., Hu W.W., Johnston L.J., Taylor T.L.et al. High dose therapy and autologous hematopoietic-cell transplantation for follicular lymphoma beyond first remission: the Stanford University experience. Biol. Blood Marrow Transplant. 7:2001;294-301.
15. Freedman A.S., Neuberg D., Mauch P., Soiffer R.J., Anderson K.C., Fisher D.C.et al. Long-term follow-up of autologous bone marrow transplantation in patients with relapsed follicular lymphoma. Blood. 94:1999;3325-3333.
16. Gribben J.G., Freedman A., Woo S.D., Blake K., Shu R.S., Freeman G.et al. All advanced stage non-Hodgkin's lymphomas with a polymerase chain reaction amplifiable breakpoint of bcl-2 have residual cells containing the bcl-2 rearrangement at evaluation and after treatment. Blood. 78:1991;3275-3280.
17. Gribben J.G., Saporito L., Barber M., Blake K.W., Edwards R.M., Griffin J.D.et al. Bone marrows of non-Hodgkin's lymphoma patients with a bcl-2 translocation can be purged of polymerase chain reaction-detectable lymphoma cells using monoclonal antibodies and immunomagnetic bead depletion. Blood. 80:1992;1083-1089.
18. Johnson P.W., Price C.G., Smith T., Cotter F.E., Meerabux J., Rohatiner A.Z.et al. Detection of cells bearing the t(1418) translocation following myeloablative treatment and autologous bone marrow transplantation for follicular lymphoma. J. Clin. Oncol. 12:1994;798-805.
19. Corradini P., Astolfi M., Cherasco C., Ladetto M., Voena C., Caracciolo D.et al. Molecular monitoring of minimal residual disease in follicular and mantle cell non-Hodgkin's lymphomas treated with high dose chemotherapy and peripheral blood progenitor cell autografting. Blood. 89:1997;724-731.
20. Ladetto M., Corradini P., Vallet S., Benedetti F., Vitolo U., Martelli M.et al. High rate of clinical and molecular remissions in follicular lymphoma patients receiving high dose sequential chemotherapy and autografting at diagnosis: a multicenter, prospective study by the Gruppo Italiano Trapianto Midollo Osseo (GITMO). Blood. 100:2002;1559-1565.
21. Di Nicola M., Siena S., Corradini P., Bregni M., Milanesi M., Magni M.et al. Elimination of bcl-2-IgH-positive follicular lymphoma cells from blood transplants with high recovery of hematopoietic progenitors by the miltenyi CD34+ cell sorting system. Bone Marrow Transplant. 18:1996;1117-1121.
22. Yerly-Motta V., Racadot E., Fest T., Bastard C., Ferrand C., Deschaseaux M.L.et al. Comparative preclinical study of three bone marrow purging methods using PCR evaluation of residual t(14;18) lymphoma cells. Leuk. Lymphoma. 23:1996;313-321.
23. Voso M.T., Hohaus S., Moos M., Haas R. Lack of t(14;18) polymerase chain reaction-positive cells in highly purified CD34+ cells and their CD19 subsets in patients with follicular lymphoma. Blood. 89:1997;3763-3768.
24. Voso M.T., Pantel G., Weis M., Schmidt P., Martin S., Moos M.et al. In vivo depletion of B cells using a combination of high dose cytosine arabinoside/mitoxantrone and rituximab for autografting in patients with non-Hodgkin's lymphoma. Br. J. Haematol. 109:2000;729-735.
25. Magni M., Di Nicola M., Devizzi L., Matteucci P., Lombardi F., Gandola L.et al. Successful in vivo purging of CD34-containing peripheral blood harvests in mantle cell and indolent lymphoma: evidence for a role of both chemotherapy and rituximab infusion. Blood. 96:2000;864-869.
26. Gribben J.G., Neuberg D., Barber M., Moore J., Pesek K.W., Freedman A.S.et al. Detection of residual lymphoma cells by polymerase chain reaction in peripheral blood is significantly less predictive for relapse than detection in bone marrow. Blood. 83:1994;3800-3807.
27. Lopez-Guillermo A., Cabanillas F., McLaughlin P., Smith T., Hagemeister F., Rodriguez M.A.et al. The clinical significance of molecular response in indolent follicular lymphomas. Blood. 91:1998;2955-2960.
28. Zwicky C.S., Maddocks A.B., Andersen N., Gribben J.G. Eradication of polymerase chain reaction detectable immunoglobulin gene rearrangement in non-Hodgkin's lymphoma is associated with decreased relapse after autologous bone marrow transplantation. Blood. 88:1996;3314-3322.
29. Dölken L., Schüler F., Dölken G. Quantitative detection of t(14;18)-positive cells by real-time quantitative PCR using fluorogenic probes. Biotechniques. 25:1998;1058-1064.
30. Hirt C., Dölken G. Quantitative detection of t(14;18)-positive cells in patients with follicular lymphoma before and after autologous bone marrow transplantation. Bone Marrow Transplant. 25:2000;419-426.
31. Voso M.T., Martin S., Hohaus S., Abdallah A., Schlenk R.F., Ho A.D.et al. Prognostic factors for the clinical outcome of patients with follicular lymphoma following high dose therapy and peripheral blood stem cell transplantation (PBSCT). Bone Marrow Transplant. 25:2000;957-964.
32. Freedman A.S., Gribben J.G., Neuberg D., Mauch P., Soiffer R.J., Anderson K.C.et al. High dose therapy and autologous bone marrow transplantation in patients with follicular lymphoma during first remission. Blood. 88:1996;2780-2786.
33. Colombat P., Cornillet P., Deconinck E., Tourani J.M., Gardembas M., Delain M.et al. Value of autologous stem cell transplantation with purged bone marrow as first-line therapy for follicular lymphoma with high tumor burden: a GOELAMS phase II study. Bone Marrow Transplant. 26:2000;971-977.
34. Horning S.J., Negrin R.S., Hoppe R.T., Rosenberg S.A., Chao N.J., Long G.D.et al. High dose therapy and autologous bone marrow transplantation for follicular lymphoma in first complete or partial remission: results of a phase II clinical trial. Blood. 97:2001;404-409.
35. Tarella C., Caracciolo D., Corradini P., Zallio F., Ladetto M., Cuttica A.et al. Long-term follow-up of advanced-stage low-grade lymphoma patients treated upfront with high dose sequential chemotherapy and autograft. Leukemia. 14:2000;740-747.
36. Seyfarth B., Kuse R., Sonnen R., Glass B., Schmitz N., Dreger P. Autologous stem cell transplantation for follicular lymphoma: no benefit for early transplant? Ann. Hematol. 80:2001;398-405.
37. Foran J.M., Apostolidis J., Papamichael D., Norton A.J., Matthews J., Amess J.A.et al. High dose therapy with autologous haematopoietic support in patients with transformed follicular lymphoma: a study of 27 patients from a single centre. Ann. Oncol. 9:1998;865-869.
38. Williams C.D., Harrison C.N., Lister T.A., Norton A.J., Blystad A.K., Coiffier B.et al. High dose therapy and autologous stem-cell support for chemosensitive transformed low-grade follicular non-Hodgkin's lymphoma: a case-matched study from the European bone marrow transplant registry. J. Clin. Oncol. 19:2001;727-735.
39. Chen C.I., Crump M., Tsang R., Stewart A.K., Keating A. Autotransplants for histologically transformed follicular non-Hodgkin's lymphoma. Br. J. Haematol. 113:2001;202-208.
40. Friedberg J.W., Neuberg D., Gribben J.G., Mauch P., Anderson K.C., Soiffer R.J.et al. Autologous bone marrow transplantation after histologic transformation of indolent B cell malignancies. Biol. Blood Marrow Transplant. 5:1999;262-268.
41. Mach-Pascual S., Legare R.D., Lu D., Kroon M., Neuberg D., Tantravahi R.et al. Predictive value of clonality assays in patients with non-Hodgkin's lymphoma undergoing autologous bone marrow transplant: a single institution study. Blood. 91:1998;4496-4503.
42. van Besien K.W., de Lima M., Giralt S.A., Moore D.F. Jr., Khouri I.F., Rondon G.et al. Management of lymphoma recurrence after allogeneic transplantation: the relevance of graft-versus-lymphoma effect. Bone Marrow Transplant. 19:1997;977-982.
43. van Besien K., Sobocinski K.A., Rowlings P.A., Murphy S.C., Armitage J.O., Bishop M.R.et al. Allogeneic bone marrow transplantation for low-grade lymphoma. Blood. 92:1998;1832-1836.
44. Martinez C., Martino R., Brunet S., Sureda A., Nomdedeu J., Garcia A.et al. Allogeneic stem cell transplantation for advanced low-grade lymphoproliferative disorders: report of six cases. Haematologica. 81:1996;330-334.
45. Verdonck L.F. Allogeneic versus autologous bone marrow transplantation for refractory and recurrent low-grade non-Hodgkin's lymphoma: updated results of the Utrecht experience. Leuk. Lymphoma. 34:1999;129-136.
46. Yakoub-Agha I., Fawaz A., Folliot O., Guillerm G., Quesnel B., Fenaux P.et al. Allogeneic bone marrow transplantation in patients with follicular lymphoma: a single center study. Bone Marrow Transplant. 30:2002;229-234.
47. Forrest D.L., Thompson K., Nevill T.J., Couban S., Fernandez L.A. Allogeneic hematopoietic stem cell transplantation for progressive follicular lymphoma. Bone Marrow Transplant. 29:2002;973-978.
48. Bertz H., Illerhaus G., Veelken H., Finke J. Allogeneic hematopoietic stem-cell transplantation for patients with relapsed or refractory lymphomas: comparison of high dose conventional conditioning versus fludarabine-based reduced-intensity regimens. Ann. Oncol. 13:2002;135-139.
49. Khouri I.F., Saliba R.M., Giralt S.A., Lee M.S., Okoroji G.J., Hagemeister F.B.et al. Nonablative allogeneic hematopoietic transplantation as adoptive immunotherapy for indolent lymphoma: low incidence of toxicity, acute graft-versus-host disease, and treatment-related mortality. Blood. 98:2001;3595-3599.